| 英文别名 |
GS9620;GS-9620;4-amino-2-butoxy-8-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-5,7-dihydropteridin-6-one;8-(3-(pyrrolidin-1-ylmethyl)benzyl)-4-amino-2-butoxy-7,8-dihydropteridin-6(5H)-one;Vesatolimod;4-amino-2-butoxy-8-(3-(pyrrolidin-1-ylmethyl)benzyl)-7,8-dihydropteridin-6(5H)-one;4-amino-2-n-butoxy-8-[3'-(pyrrolidin-1"-ylmethyl)-benzyl]-5,6,7,8-tetrahydropteridin-6-one;CS-1352;GS 9620;O8M467C50G;4-azanyl-2-butoxy-8-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-5,7-dihydropteridin-6-one;Vesatolimod [INN];Vesatolimod [USAN:INN];Vesatolimod (USAN/INN);SCHEMB;UNII-O8M467C50G;4-amino-2-butoxy-8-(3-(1-pyrrolidinylmethyl)benzyl)-7,8-dihydro-6(5H)-pteridinone;HY-15601;DTXSID40153741;MFCD25372045;EX-A2065;AC-30275;DA-33595;4-Amino-2-butoxy-8-({3-[(pyrrolidin-1-yl)methyl]phenyl}methyl)-7,8-dihydropteridin-6(5H)-one;4-amino-2-butoxy-8-({3-[(pyrrolidin-1-yl)methyl]phenyl}methyl)-5,6,7,8-tetrahydropteridin-6-one;VFOKSTCIRGDTBR-UHFFFAOYSA-N;AS-74316;VESATOLIMOD [WHO-DD];BDBM50440284;D11003;GS-9620(Vesatolimod)?;NCGC00390283-02;VESATOLIMOD [USAN];SB16757;9JR;4-Amino-2-butoxy-7,8-dihydro-8-[[3-(1-pyrrolidinylmethyl)phenyl]methyl]-6(5H)-pteridinone;DB12687;C22H30N6O2;1228585-88-3;Q27285487;NCGC00390283-03;SY028554;NCGC00390283-01;NS00073077;SCHEMBL10083191;AMY41043;s7221;CCG-268776;AKOS025290740;BCP08305;6(5H)-Pteridinone, 4-amino-2-butoxy-7,8-dihydro-8-((3-(1-pyrrolidinylmethyl)phenyl)methyl)-;CHEMBL2424780;HMS3750I03;BRD-K73585091-001-02-3;BRD-K73585091-001-02-3;BRD-K73585091-001-01-5;BRD-K73585091-001-02-3;BRD-K73585091-001-01-5;4-Amino-2-butoxy-8-(3-(pyrrolidin-1-ylmethyl)benzyl)-7,8-dihydropteridin-6(5H)-one;BRD-K73585091-001-01-5;4-Amino-2-butoxy-8-(3-(pyrrolidin-1-ylmethyl)benzyl)-7,8-dihydropteridin-6(5H)-one;4-Amino-2-butoxy-8-(3-(pyrrolidin-1-ylmethyl)benzyl)-7,8-dihydropteridin-6(5H)-one;4-Amino-2-butoxy-8-(3-(pyrrolidin-1-ylmethyl)benzyl)-7,8-dihydropteridin-6(5H)-one;4-Amino-2-butoxy-8-(3-(pyrrolidin-1-ylmethyl)benzyl)-7,8-dihydropteridin-6(5H)-one |
微信公众号
客服
